Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Cirrhosis

  Free Subscription


06.08.2018

1 BMC Gastroenterol
1 Dig Dis Sci
1 Gastroenterology
2 Hepatology
1 Intern Med
1 J Gastroenterol Hepatol
8 J Hepatol
1 Lancet
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Gastroenterol

  1. YU R, Shi Q, Liu L, Chen L, et al
    Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis.
    BMC Gastroenterol. 2018;18:51.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  2. GIANNINI EG, Coppo C, Romana C, Camerini GB, et al
    Long-Term Follow-Up Study of Liver-Related Outcome After Bilio-Pancreatic Diversion in Patients with Initial, Significant Liver Damage.
    Dig Dis Sci. 2018 Apr 9. pii: 10.1007/s10620-018-5052.
    PubMed     Text format     Abstract available


    Gastroenterology

  3. TRIPATHI DM, Vilaseca M, Lafoz E, Garcia-Caldero H, et al
    Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.
    Gastroenterology. 2018 Jul 25. pii: S0016-5085(18)34810.
    PubMed     Text format     Abstract available


    Hepatology

  4. GARCIA-TSAO G, Fuchs M, Shiffman M, Borg BB, et al
    Emricasan (IDN-6556) Lowers Portal Pressure in Patients with Compensated Cirrhosis and Severe Portal Hypertension.
    Hepatology. 2018 Jul 31. doi: 10.1002/hep.30199.
    PubMed     Text format     Abstract available

  5. CORTES E, Lachowski D, Rice A, Chronopoulos A, et al
    RAR-beta is downregulated in HCC & cirrhosis and its expression inhibits myosin-driven activation and durotaxis in hepatic stellate cells.
    Hepatology. 2018 Jul 28. doi: 10.1002/hep.30193.
    PubMed     Text format     Abstract available


    Intern Med

  6. KOMURA T, Ohta H, Seike T, Shimizu Y, et al
    The Efficacy of Corticosteroid Therapy in a Patient with Nonalcoholic Steatohepatitis Overlapping Autoimmune Hepatitis: A Case Report.
    Intern Med. 2017 Nov 20. doi: 10.2169/internalmedicine.8887.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  7. KIM TH, Lee HA, Seo YS, Lee YR, et al
    Assessment and prediction of acute kidney injury in patients with decompensated cirrhosis with serum cystatin C and urine N-acetyl-beta-D-glucosaminidase.
    J Gastroenterol Hepatol. 2018 Jul 30. doi: 10.1111/jgh.14387.
    PubMed     Text format     Abstract available


    J Hepatol

  8. PIETRANGELO A
    Mechanisms of iron hepatotoxicity.
    J Hepatol. 2016 Feb 5. pii: S0168-8278(16)00080.
    PubMed     Text format    

  9. VAN MEER S, Lieveld FI, van Erpecum KJ
    Patients' misconceptions about surveillance for hepatocellular carcinoma: Education is needed.
    J Hepatol. 2016 Jun 16. pii: S0168-8278(16)30274.
    PubMed     Text format    

  10. LI J, Li S
    Response to Letter to the Editor on comments on "miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression. Li J, et al. J Hepatol 2013;58:522-528."
    J Hepatol. 2016 Jul 4. pii: S0168-8278(16)30315.
    PubMed     Text format    

  11. SCHUELLER F, Roy S, Trautwein C, Luedde T, et al
    miR-122 expression is not regulated during activation of hepatic stellate cells.
    J Hepatol. 2016 Jul 4. pii: S0168-8278(16)30308.
    PubMed     Text format    

  12. ROMBOUTS K, Bemeur C, Rose CF
    Targeting the muscle for the treatment and prevention of hepatic encephalopathy.
    J Hepatol. 2016 Aug 30. pii: S0168-8278(16)30474.
    PubMed     Text format    

  13. VENKATESH SK, Loomba R
    Editorial: Non-invasive estimation of HVPG by combined structural and hemodynamic evaluation of portal hypertension using quantitative magnetic resonance imaging.
    J Hepatol. 2016 Sep 20. pii: S0168-8278(16)30509.
    PubMed     Text format    

  14. FELIPO V, Montagnese S
    A rare and revealing glimpse of the cerebrospinal fluid of patients with hepatic encephalopathy.
    J Hepatol. 2016 Sep 24. pii: S0168-8278(16)30538.
    PubMed     Text format    

  15. MAROT A, Henrion J, Knebel JF, Deltenre P, et al
    Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis.
    J Hepatol. 2018 Jul 23. pii: S0168-8278(18)32160.
    PubMed     Text format    


    Lancet

  16. BARNETT R
    Liver cirrhosis.
    Lancet. 2018;392:275.
    PubMed     Text format    


    PLoS One

  17. MANGIA A, Losappio R, Cenderello G, Potenza D, et al
    Real life rates of sustained virological response (SVR) and predictors of relapse following DAA treatment in genotype 3 (GT3) patients with advanced fibrosis/cirrhosis.
    PLoS One. 2018;13:e0200568.
    PubMed     Text format     Abstract available

  18. ONICIU DC, Hashiguchi T, Shibazaki Y, Bisgaier CL, et al
    Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM model of NASH.
    PLoS One. 2018;13:e0194568.
    PubMed     Text format     Abstract available

  19. AXLEY P, Mudumbi S, Sarker S, Kuo YF, et al
    Patients with stage 3 compared to stage 4 liver fibrosis have lower frequency of and longer time to liver disease complications.
    PLoS One. 2018;13:e0197117.
    PubMed     Text format     Abstract available

  20. YAMAZAKI T, Joshita S, Umemura T, Usami Y, et al
    Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C.
    PLoS One. 2018;13:e0195632.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: